标记试剂盒

Platelet Preparation (Viral Immunity & Pathogenesis Group, the Université Catholique de Louvain)

OUTLINEInordertoavoidplateletactivationallmanipulationsmustbeperformedasquicklyandasacurateaspossIBLe.Workoniceifpossible!

Thisprotocolisbasedondifferentialcentrifugationthatallowstoseparateplateletsfrombloodcells.AlsoyoucanuseRobinsonprocedure(consulttheHANDBOOKOFFLOWCYTOMETRYMETHODS)

PROTOCOL

  1. Bleedanimalsviatheplexusretroorbitalisorthetailveinunderetheranesthesia
  2. Collectbloodinto1,5EppendorftubeswithACD(acid-citrate-dextrose;SigmaC-3821)=1volofACD:3volofblood:6.6volofNaN30,05%-PBS
  3. Cetrifugeat216-220g,5-7min,10ѓC
  4. Take&saveat4ѓCPRP(platelet-richplasma)
  5. Add1mlofeitherNaN30,05%-PBSorBSGCtotheremainigeythrocytesandothercells
  6. Cetrifugeat216-220g,5-7min,10ѓC
  7. Take&saveat4ѓCPRP(platelet-richplasma)
  8. Add1mlofeitherNaN30,05%-PBSorBSGCtotheremainigeythrocytesandothercells
  9. Cetrifugeat216-220g,5-7min,10ѓC
  10. Take&saveat4ѓCPRP(platelet-richplasma)
  11. PoolsavedPRP
  12. Cetrifugeat1613g,10min,10ѓC
  13. Aspiratesupernatant(SN)
  14. ResUSPendsedimentedplateletsineitherEDTA1%-NaCl0.9%orBSGC
  15. Cetrifugeat216-220g,5-7min,10ѓC
  16. ResuspendinineitherEDTA1%-NaCl0.9%orBSGC.Countplatelets
  17. TransferSNintoanothertube,saveat4ѓC

SOLUTIONS

  1. ACD=0.1mol/Ltrisodiumcitrate,0.11mol/Ldextrose,and71mmol/Lcitricacidmonohydrate
  2. ACDpH4.9=trisodiumcitratedihydrate22g/L+citricacidmonohydrate8g/L+dextrose24.5g/L
  3. NaN30.05%-PBS(for500ml)=100mlPBS(x5)+400mlddH2O+0.25gNaN3pH7.0-7.2
  4. PBS(x5)(phosphatebuffersalinex5)(for5L)=180gNaCl+37gNa2HPO4*2H2O+10.75gKH2PO4+ddHOto5L
  5. EDTA1%-NaCl0.9%(for500ml)=5gEDTA+0.9%NaClto500mlpH7.0
  6. BSGC=8.6mMNa2HPO4,1.6mMKH2PO4,0.12MNaCl,0.9mMEDTA,13.6mMNacitrate,11.1mMglucose,pH7.3(Levinetal,1999)

ADDITIONALINFO

  1. it"spossibletobleedmicebycardiacpunctureunderetheranesthesia.
  2. it"spossibletocollectbloodintosodiumcitrate3.8%(0.1mol/L)=1volcitrate:9volblood:50volbufferedsaline-glucose-citratepH7.3//orheparin7.5U/ml
  3. RCF=1.12xrx(RPM/100)x(RPM/100)whereRCF-relativecentrifugalforceing,r-centrifugerADIusinmm,RPM-rotationspermininrpm
  4. ToavoidcontaminationofPRPwithleukocytesanderythrocytestakePRP-upper&middlelayers

REFERENCES

  1. Semple,J.W.,Speck,E.R.,Cosgrave,D.,Lazarus,A.H.,Blanchette,V.S.andFreedman,J.(1999).ExtremeleukoreductionofmajorhistocompatibilitycomplexclassIIpositiveBcellsenhancesallogeneicplateletimmunity.Blood93(2):713-20.
  2. Jin,J.,Quinton,T.M.,Zhang,J.,Rittenhouse,S.E.andKunapuli,S.P.(2002).Adenosinediphosphate(ADP)-inducedthromboxaneA(2)generationinhumanplateletsrequirescoordinatedsignalingthroughintegrinalpha(IIb)beta(3)andADPreceptors.Blood99(1):193-8.
  3. Khetawat,G.,Faraday,N.,Nealen,M.L.,Vijayan,K.V.,Bolton,E.,Noga,S.J.andBray,P.F.(2000).Humanmegakaryocytesandplateletscontaintheestrogenreceptorbetaandandrogenreceptor(AR):testosteroneregulatesARexpression.Blood95(7):2289-96.

================  蚂蚁淘在线  ================

免责声明:本文仅代表作者个人观点,与本网无关。其创作性以及文中陈述文字和内容未经本站证实,对本文以及其中全部或者部分内容、文字的真实性、完整性、及时性本站不做任何保证或承诺,请读者仅作参考,并请自行核实相关内容

版权声明:未经蚂蚁淘在线授权不得转载、摘编或利用其他方式使用上述作品。已经经本网授权使用作品的,应该授权范围内使用,并注明“来源:蚂蚁淘在线”。违反上述声明者,本网将追究其相关法律责任。